You have 9 free searches left this month | for more free features.

City

Perugia (1)

Ranica (1)

Stony Brook (1)

Condition

Colorectal Cancer (1)

Early Nephropathy (1)

Intermittent Claudication (1)

Type 2 Diabetes (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Mario Negri Institute for Pharmacological Research (1)

NicOx Research Institute S.r.l. (1)

Stony Brook University (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

biopsy (1)

laboratory biomarker analysis (1)

ncx-4016 (1)

ncx4016 placebo (1)

nitric oxide-releasing acetylsalicylic acid derivative (1)

nitroaspirin (1)

Study Documents

Intervention Type

drug (3)

other (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Nitroaspirin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Type 2 Diabetes, Early Nephropathy Trial in Ranica (nitroaspirin)

Terminated

Type 2 Diabetes
Early Nephropathy

nitroaspirin

Ranica, Bergamo, Italy

Clinical Research Center for Rare Diseases

Apr 8, 2015

Intermittent Claudication Trial in Perugia (NCX-4016, NCX4016 )

Completed

Intermittent Claudication

NCX-4016
NCX4016 placebo

Perugia, Italy

Ospedale di Perugia

Jan 18, 2011

Colorectal Cancer Trial in Stony Brook (drug, other, procedure)

Completed

Colorectal Cancer

nitric oxide-releasing acetylsalicylic acid derivative
+2 more

Stony Brook, New York

Stony Brook University Cancer Center

Feb 6, 2009